<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">According to the guidelines, Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (7th edition), issued by National Health Commission &amp; State Administration of Traditional Chinese Medicine, several agents are recommended for the treatment of COVID-19 including antivirals such as interferon alfa (IFN-α), lopinavir/ritonavir, arbidol chloroquine phosphate, and ribavirin. In severe cases with extensive lung lesions and with an increased IL-6 level, tocilizumab is suggested (
 <xref rid="tbl1" ref-type="table">Table 1</xref> ). For COVID-19 patients with a critical illness, glucocorticoids are recommended for a short period (3–5 days). Besides these, Traditional Chinese Medicines are also recommended in the guidelines for the treatment of various levels of COVID-19 cases (
 <xref rid="bib26" ref-type="bibr">Commision, 2020</xref>). In silico studies have demonstrated that anti-SARS-CoV-2 compounds might be present in Chinese herbal remedies used traditionally for the treatment of viral respiratory infection (
 <xref rid="bib162" ref-type="bibr">Zhang et al., 2020</xref>), showing the potential of natural compounds against coronavirus. Various potent nutraceuticals might help in the prevention and control of RNA virus infections, including coronavirus by increasing type 1 interferon production via amplifying either the signaling of toll-like receptor 7 (TLR7) or mitochondrial antiviral-signaling proteins (MAVS) (
 <xref rid="bib95" ref-type="bibr">McCarty and DiNicolantonio, 2020</xref>).
</p>
